Portfolio company
Arboretum LifeSciences, Inc.
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This molecular information company develops genetic testing and AI-driven data platforms for biopharmaceutical firms and healthcare providers to enable precision medicine for common diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Arboretum
The company provides genetic testing and molecular data platforms to healthcare systems and biopharmaceutical developers for common disease research and precision medicine.
TMA Precision Health
This company provides a clinical decision support platform using genomic data and medical records to improve rare disease diagnosis for health systems and pharmaceutical partners.
Arbor Biotechnologies
This company develops programmable gene-editing tools and genetic medicines to treat patients with liver and central nervous system diseases.
Healthcare insights platform
This company provides a data analytics platform that integrates genetic information and clinical research to assist pharmaceutical firms in developing precision medicine and treatments.
Preview Health
This company develops an artificial intelligence molecular profiling platform to help pharmaceutical companies and clinicians detect diseases and evaluate drug responses through biological samples.
1910 Genetics
The company develops AI-driven drug discovery platforms and automated wet labs to provide pharmaceutical firms with small molecule and protein therapeutic development services.
Genomenon
This company develops genomic search engines and data platforms for pharmaceutical companies and clinical laboratories to assist in disease diagnosis and drug development.
Multiomic Health
This company develops an artificial intelligence platform for discovering precision medicines and biomarkers for patients with metabolic syndrome-related chronic diseases.
